Favourable use of non-boosted fosamprenavir in patients treated with warfarin.
Honda
H
H
Gatanaga
H
H
Matsumura
J
J
Kamimura
M
M
Goto
K
K
Tsukada
K
K
Honda
M
M
Teruya
K
K
Kikuchi
Y
Y
Oka
S
S
D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy; D002219:Carbamates / Q000627:therapeutic use*; D004347:Drug Interactions; D005663:Furans; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D007564:Japan; D008297:Male; D008875:Middle Aged; D010755:Organophosphates / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*; D016896:Treatment Outcome; D014859:Warfarin / Q000627:therapeutic use*
D019380:Anti-HIV Agents; D000925:Anticoagulants; D002219:Carbamates; D005663:Furans; D017320:HIV Protease Inhibitors; D010755:Organophosphates; D013449:Sulfonamides; D014859:Warfarin; C426859:fosamprenavir